Ufp Technologies (UFPT) EBITDA Margin (2010 - 2026)

Ufp Technologies (UFPT) reported EBITDA Margin of 10.23% for Q1 2026, down 294.0% on a YoY basis from 5.27% in Q1 2025, and down 14.28% quarter-over-quarter from 11.93% in Q4 2025.

Ufp Technologies (UFPT) EBITDA Margin (2010 - 2026) Analysis & Trends

Ufp Technologies has reported EBITDA Margin for 17 years, with the latest figure at 10.23% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin fell 294.0% year-over-year to 10.23%; the trailing twelve-month figure through Mar 2026 stood at 11.9% (up 59.0% YoY), and the FY2025 full-year result was 12.64%, up 182.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 10.23%, down from 11.93% in the prior quarter.
  • The five-year high for EBITDA Margin was 18.37% in Q3 2022, with the low at 7.35% in Q1 2022.
  • Historically, EBITDA Margin has averaged 11.51% across 5 years, with a median of 11.74% in 2022.
  • Annual changes were most pronounced in 2022 — EBITDA Margin surged 1090 bps — and 2023, when it slumped 756 bps.
  • Ufp Technologies' EBITDA Margin stood at 11.74% in 2022, then grew by 7 bps to 12.56% in 2023, then slumped by 36 bps to 8.08% in 2024, then jumped by 48 bps to 11.93% in 2025, then declined by 14 bps to 10.23% in 2026.
  • The last three EBITDA Margin figures came in at 10.23% (Q1 2026), 11.93% (Q4 2025), and 10.63% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 12.05%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 15.55%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 16.24%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.04%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 19.94%
10 Ufp Technologies 1.85 Bn 1.83 Bn 44.36 Mn 10.23%

Historic Data

Download Data
DateValue
Mar 31, 2026 10.23%
Dec 31, 2025 11.93%
Sep 30, 2025 10.63%
Jun 30, 2025 14.87%
Mar 31, 2025 13.17%
Dec 31, 2024 8.08%
Sep 30, 2024 12.01%
Jun 30, 2024 12.14%
Mar 31, 2024 11.53%
Dec 31, 2023 12.56%
Sep 30, 2023 10.82%
Jun 30, 2023 11.92%
Mar 31, 2023 10.47%
Dec 31, 2022 11.74%
Sep 30, 2022 18.37%
Jun 30, 2022 7.86%
Mar 31, 2022 7.35%
Dec 31, 2021 5.71%
Sep 30, 2021 7.47%
Jun 30, 2021 9.31%